Completed PHASE4 INTERVENTIONAL 4-arm NCT00680732

Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component

Prevention of Intrauterine Growth Retardation in Hounde District, Burkina Faso: the Malaria Component

Sponsor: Centre Muraz

Interventions Chloroquine (CQ) Iron and folic acid (IFA) Multiple micronutrients supplements (MMS) Sulphadoxyne-pyrimethamine (SP)

Updated 5 times since 2017 Last updated: Sep 12, 2010 Started: Jun 30, 2003 Primary completion: Oct 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00680732, this PHASE4 trial focuses on Malaria and Malaria in Pregnancy and remains completed. Sponsored by Centre Muraz, it has been updated 5 times since 2003, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Muraz
Departments of Parasitology and Public Health, ITM, Antwerp, Belgium
Institute of Tropical Medicine, Belgium
Laboratoire National de Santé Publique, Ouagadougou, Burkina Faso

Data source: Institute of Tropical Medicine, Belgium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bobo-Dioulasso, Burkina Faso